Effects of Microgalvanic Current on Body Satisfaction and Quality of Life in Women With Striae Alba
1 other identifier
interventional
61
1 country
1
Brief Summary
The purpose of this randomized clinical trial is to determine whether microgalvanic current can improve quality of life and body satisfaction in women aged 20 to 35 years with striae albae (white stretch marks). The primary research question is: Does microgalvanic current improve body satisfaction or quality of life? The secondary research question is: Does microgalvanic current lead to clinical improvement of striae albae? Participants will be randomly assigned to one of two groups: Control group: device turned off, receiving microneedling only; and Intervention group: active device, receiving microneedling combined with microgalvanic current. All participants will undergo 10 weekly treatment sessions, each lasting approximately 50 minutes. Baseline and post-intervention assessments will be conducted to evaluate primary and secondary outcomes. Standardized photographs of the affected areas will be obtained to assess clinical improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedMarch 6, 2026
March 1, 2026
1.6 years
February 5, 2026
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quality of Life Assessed by Dermatology Life Quality Index (DLQI)
Change in quality of life assessed using the Dermatology Life Quality Index (DLQI), Brazilian validated version (DLQI-BRA), developed by Finlay and Khan (1994). The DLQI is a 10-item questionnaire covering six domains (symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment). Total scores range from 0 to 30, with higher scores indicating greater impairment in quality of life.
Baseline (before the first treatment session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).
Impact of Stretch Marks on Quality of Life Assessed by Structured Interview
Change in stretch mark-specific quality of life assessed using the Structured Interview on the Impact of Stretch Marks on Quality of Life, developed for this study. The instrument consists of 9 Likert-scale questions (0-4 per item), evaluating the impact of stretch marks on self-image, self-esteem, and social behavior. Total scores range from 0 to 36, with higher scores indicating greater perceived negative impact.
Baseline (before the first treatment session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).
Body Satisfaction
Change in participants' body satisfaction, assessed using the Body Shape Questionnaire (BSQ) developed by Cooper et al. (1987) and adapted for the Brazilian population by Di Pietro et al. (2009). The BSQ consists of 34 self-administered items rated on a 6-point scale (1 = never to 6 = always), with a total score of up to 204 points. Higher scores indicate greater body dissatisfaction. The questionnaire will be administered before the beginning of the intervention and after the last session to assess possible changes in body satisfaction levels following the treatment.
Baseline, pre- (before the first session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).
Secondary Outcomes (1)
Clinical Improvement of Striae Alba Assessed by Ordinal Photographic Scale (GAIS)
Baseline (before the first treatment session) and after completion of the 10th treatment session (approximately 10 weeks).
Other Outcomes (2)
Variability Related to Skin Phototype
Baseline (before the first treatment session) and post-intervention (after completion of 10 treatment sessions, approximately 10 weeks).
Pain Perception During Treatment Sessions
During each of the 10 treatment sessions (weekly sessions for approximately 10 weeks).
Study Arms (2)
Sham Microgalvanic Current
PLACEBO COMPARATORParticipants in this group will receive microneedling treatment only, using the device turned off. This allows evaluation of the effects of microneedling without the microgalvanic current. Pre- and post-intervention assessments will be conducted to measure body satisfaction, quality of life, and clinical improvement of white stretch marks (striae albae). Photographs of the affected areas will be taken during each session.
Microgalvanic Current
EXPERIMENTALParticipants in this group will receive microneedling combined with active microgalvanic current using the device. This allows evaluation of the combined effects of microneedling and microgalvanic current on body satisfaction, quality of life, and clinical improvement of white stretch marks (striae albae). Pre- and post-intervention assessments and photographs will be collected in each session.
Interventions
Participants in this group will receive microneedling treatment with the device turned off, providing only the mechanical stimulation of microneedling without the microgalvanic current. This allows evaluation of the effects of microneedling alone. The procedure consists of 10 weekly sessions lasting approximately 50 minutes each. Photographs of the affected areas will be taken during each session.
Participants in this group will receive microneedling combined with active microgalvanic current using the same device. This procedure aims to evaluate the combined effects of microneedling and galvanic current on body satisfaction, quality of life, and the clinical appearance of white stretch marks (striae albae). The procedure consists of 10 weekly sessions lasting approximately 50 minutes each. Photographs of the treated areas will be taken during each session.
Eligibility Criteria
You may qualify if:
- Biologically female individuals
- Age between 20 and 35 years
- Presence of white stretch marks (striae albae)
- Availability to participate for the entire duration of the study
- Properly and completely signed Informed Consent Form, Image Use Agreement and all study questionnaires
You may not qualify if:
- Cardiac arrhythmia or pacemaker
- Hemophilia
- Uncontrolled arterial hypertension
- Diabetes mellitus
- Predisposition to keloid formation
- Hypersensitivity to electrical current stimulation
- Pregnancy
- Any abnormalities or diseases (e.g., Cushing's syndrome) that impair skin healing
- Open wounds
- Current or recent use of corticosteroids, steroids or anti-inflammatory medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Jequitinhonha and Mucuri Valleys
Diamantina, Minas Gerais, 39100000, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2026
First Posted
March 6, 2026
Study Start
April 8, 2024
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared due to privacy and ethical considerations related to clinical and photographic data. De-identified data underlying the results may be made available upon reasonable request to the corresponding author, subject to institutional approval and compliance with ethical and data protection regulations.